| Site Map | Webmaster | ||||
Natural Selection, Inc. Publishes Article in Pharmaceutical Discovery
La Jolla, CA – Dr. Gary B. Fogel, Vice President, has published an article titled "Gene Expression Analysis Using Methods of Computational Intelligence" in the October issue of Pharmaceutical Discovery. The article investigates the use of evolutionary computation and artificial neural networks for pattern recognition of microarray data. Dr. Fogel concludes that as microarray usage continues to expand exponentially as a diagnostic tool, computational tools to support microarray analysis must expand as well, particularly in class prediction and class discovery. He argues that applying computational tools such as neural networks, evolutionary algorithms, and evolutionary computation to microarray data analysis are the best-fit methods for maximizing rapid accurate predictive analyses.
Natural Selection, Inc. was founded in 1993 to address complex problems in industry, medicine, and defense. The company possesses unique expertise in computational intelligence techniques, including evolutionary computation, neural networks, and fuzzy logic. The corporation's research efforts support the discovery of new pharmaceuticals, the automated detection and discovery of important patterns and processes in bioinformatics and medical informatics, computer-assisted diagnosis, and a variety of military and industrial projects.
For more information, please contact:
Dr. Gary B. Fogel
Vice President
Natural Selection, Inc.
3333 N. Torrey Pines Ct.
Suite 200
La Jolla, CA, 92037
tel: (858) 455-6449
fax: (858) 455-1560
gfogel@natural-selection.com
and please visit our web site at http://www.natural-selection.com/.